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ABSTRAK
Latar belakang: fungsi jantung pada pasien dengan syok septik pada tingkat sel dapat dinilai dengan mengukur 
tingkat troponin I dan NT Pro BNP. Saturasi oksigen vena diukur untuk mengevaluasi pengiriman dan pengambilan 
oksigen oleh jaringan organ. Studi kami dapat memberikan pengetahuan dan pemahaman yang lebih besar 
tentang patofisiologi gangguan kardiovaskular pada pasien dengan syok septik. Penelitian ini bertujuan untuk 
mengevaluasi peran ekokardiografi, biomarker kardiovaskular, saturasi oksigen vena dan fungsi ginjal sebagai 
prediktor tingkat kematian pada pasien dengan syok septik. Metode: ini adalah studi kohort prospektif pada pasien 
dengan infeksi, hipotensi (MAP <65 mmHg) dan tingkat serum laktat >2 mmol/L. Pada hari pertama dan kelima, 
pasien septik menjalani pemeriksaan ekokardiografi dan darah. Analisis statistik yang digunakan dalam penelitian 
kami meliputi uji-t atau uji Mann-Whitney untuk data numerik dan uji chi-square untuk data nominal kelompok dua 
variabel; sedangkan untuk analisis multivariat, kami menggunakan model Cox Regression. Hasil: pada 10 hari 
pengamatan, kami menemukan 64 (58%) pasien meninggal dan 47 (42%) pasien selamat. Usia rata-rata pasien 
adalah 48 (SB 18) tahun. Pasien dengan fraksi ejeksi ventrikel kiri abnormal (LVEF) memiliki risiko kematian 
1,6 kali lebih besar dibandingkan dengan LVEF normal (RR 1,6; p = 0,034). Pasien dengan level troponin I yang 
abnormal menunjukkan risiko kematian yang lebih tinggi sebanyak 1,6 kali (RR: 1,6; p = 0,004). Pasien dengan 
gangguan fungsi ginjal memiliki risiko kematian 1,5 kali (RR 1,5; p = 0,024). Pasien dengan tingkat troponin I 
yang abnormal dan / atau gangguan fungsi ginjal menunjukkan peningkatan risiko kematian; Namun, mereka yang 
memiliki kadar troponin I normal dan gangguan fungsi ginjal juga menunjukkan peningkatan risiko kematian. 
Analisis multivariat mengungkapkan bahwa fraksi ejeksi ventrikel kiri dan level troponin I dapat berfungsi sebagai 
prediktor mortalitas pada pasien dengan syok septik. (HR 1,99; 95% CI: 1,099 ̶ 3,956; p = 0,047 dan HR: 1,83; 
95% CI: 1,049 ̶ 3,215; p = 0,043). Kesimpulan: fraksi ejeksi ventrikel kiri dan biomarker seperti level troponin I 
merupakan prediktor mortalitas pada pasien syok septik.
Kata kunci: ekokardiografi, kematian, NT Pro BNP, syok septik, troponin I.
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ABSTRACT
Background: cardiac function in patients with septic shock at the cellular level can be assessed by measuring 
troponin I and NT Pro BNP levels. Venous oxygen saturation is measured to evaluate oxygen delivery and 
uptake by organ tissue. Our study may provide greater knowledge and understanding on pathophysiology of 
cardiovascular disorder in patients with septic shock. This study aimed to evaluate the roles of echocardiography, 
cardiovascular biomarkers, venous oxygen saturation and renal function as predictors of mortality rate in 
patients with septic shock. Methods: this is a prospective cohort study in patients with infections, hypotension 
(MAP < 65 mmHg) and serum lactate level of > 2 mmol/L. On the first and fifth days, septic patients underwent 
echocardiography and blood tests. Statistical analysis used in our study included t-test or Mann-Whitney test 
for numeric data and chi-square test for nominal data of two-variable groups; while for multivariate analysis, 
we used Cox Regression model. Results: on 10 days of observation, we found 64 (58%) patients died and 47 
(42%) patients survived. The mean age of patients was 48 (SD 18) years. Patients with abnormal left ventricular 
ejection fraction (LVEF) had 1.6 times greater risk of mortality than those with normal LVEF (RR 1.6; p = 
0.034). Patients with abnormal troponin I level showed higher risk of mortality as many as 1.6 times (RR: 1.6; 
p = 0.004). Patients with impaired renal function had 1.5 times risk of mortality (RR 1.5; p = 0.024). Patients 
with abnormal troponin I level and/or impaired renal function showed increased mortality risk; however, those 
with normal troponin I level and impaired renal function also showed increased mortality risk. Multivariate 
analysis revealed that left ventricular ejection fraction and troponin I level may serve as predictors of mortality 
in patients with septic shock. (HR 1.99; 95% CI: 1.099  ̶  3.956 ; p = 0.047 and HR: 1.83 ; 95%CI: 1.049  ̶ 
3,215 ; p = 0.043). Conclusion: left ventricular ejection fraction and biomarkers such as troponin I level are 
predictors of mortality in septic shock patients.
Keywords: echocardiography, death, NT Pro BNP, septic shock, troponin I.
INTRODUCTION
According to The Third International 
Consensus Definitions for Sepsis and Septic 
Shock (Sepsis-3 Consensus) in 2016, sepsis 
is a life-threatening organ dysfunction due to 
a disorder of host regulation in response to 
infections. In clinical practice, organ dysfunction 
is usually assessed using the Sequential (Sepsis-
Related) Organ Failure Assessment (SOFA) 
and it is defined in patients with score of ≥ 2. 
The mortality rate of septic patients during 
hospitalization is more than 10%. Septic shock 
is a subset of sepsis with circulatory, cellular, 
and metabolic abnormalities associated with 
mortality risk. Septic shock can be clinically 
identified when the patients requires vasopressor 
to maintain mean arterial blood pressure (MAP) 
of 65 mmHg or more, and their serum lactate 
level is greater than 2 mMol/L (>18 mg/dL) in 
the absence of hypovolemia. The mortality rate 
of patients with sepsis during treatment is more 
than 40%.1
Patients with infectious diseases and 
possibility of worsening condition in spite of 
having treatment or those with condition that 
may lead to sepsis can be assessed rapidly 
using quickSOFA (qSOFA). It uses three criteria 
assigning one point for (1) respiratory rate >22 
breaths/minute; (2) altered mental status; or (3) 
blood pressure ≤100 mmHg.2 Moreover, there are 
at least two of those criteria may occur together 
in clinical setting. Using qSOFA, cardiovascular 
system is assessed by measuring mean arterial 
pressure; however, the mean arterial pressure 
does not reflect cardiac function, e.g. patients 
with peripartum cardiomyopathy may have 
normal mean arterial pressure but still have 
reduced cardiac function.3
The heart works as a pump to maintain blood 
circulation and the blood consists of oxygen, 
nutrition and substrate to protect cell integrity.1 
Cardiac dysfunction can be categorized into 
two groups, which are systolic dysfunction 
and diastolic dysfunction.  The assessment of 
systolic function is based on observation of 
myocardial contractility by measuring Left 
Ventricular Ejection Fraction for the left heart4 
and Tricuspid Annular Plane Systolic Excursion 
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(TAPSE) for the right heart;5 while diastolic 
dysfunction or reduced compliance can be 
assessed using echocardiography and measuring 
the E/e’ ratio.6 Diastolic dysfunction will 
increase pulmonary capillary wedge pressure 
and generate pulmonary edema. Cardiac index, a 
hemodynamic parameter associated with cardiac 
performance, can be assessed by measuring the 
amount of blood pumped from the heart to the 
whole body in each minute. Cardiac output is 
measured by multiplication of stroke volume 
and heart rate in one minute. Stroke volume can 
be assessed by measuring Time Velocity Integral 
and area of aortic valves opening.7
Cardiac function in patients with septic shock 
at the cellular level can be assessed by measuring 
troponin I and NT Pro BNP levels. Troponin I 
can be found in patients with sepsis shock due 
to changes in permeability or the presence of 
micro-circular thrombosis.8 NT Pro BNP release 
occurs due to myocardial stretching in patients 
with septic shock.9 The amount of troponin I and 
NT Pro BNP in blood circulation also depend 
on renal function.10 Venous oxygen saturation is 
measured to evaluate oxygen delivery and uptake 
by organ tissue.11 It is expected that our study may 
provide greater knowledge and understanding on 
pathophysiology of cardiovascular disorder in 
patients with septic shock. The study was aimed 
to identify the roles of cardiovascular parameters 
in order to initiate prompt and appropriate 
treatment for patients with septic shock and it 
may also serve as a complementary aid to the 
clinical practice guidelines.
METHODS
Our study was an observational study with a 
cohort prospective design and it was conducted 
at Tangerang District General Hospital, in Banten 
Province between December 2013 and February 
2016. Sampling was done consecutively until the 
number of samples was reached.
Subjects
Subjects included in the study were patients 
with sepsis shock, i.e. those with the identified 
infection, hypotension (MAP of <65mmHg) and 
serum lactate level of >2 mmol/L, who were 
recruited at Tangerang District Hospital. The 
exclusion criteria were patients with heart failure, 
acute coronary syndrome, heart valve disorders 
due to rheumatic heart disease or congenital heart 
disease and patients who were unable to undergo 
echocardiography procedures because the field 
of view was difficult to obtain or due to other 
technical aspects.
Protocol
Patients were examined on day 1, i.e. when 
they were first admitted to hospital; and on day 
5 when the patients received treatment. The 
research methodology flow chart is described 
as follows:
Echocardiography was performed using 
Philip HD 15 (R). The assessment of diastolic 
function was carried out by evaluating the 
E/e’ ratio according to the ASE /EACVI 
Guidelines and Standards Recommendation 
for the Evaluation of Left Ventricular Diastolic 
Function by Echocardiography, An Update 
from American Society of Echocardiography 
and European Association of Cardiovascular 
Imaging (2016).5 The LVEF was measured using 
Simpson’s method, which provided all four 
cardiac chamber views. The LVEF was calculated 
from the left ventricular chamber during 
diastole and systole following the guidelines 
issued by the Recommendation for Cardiac 
Chamber Quantification by Echocardiography 
in Adults: An Update from the American 
Society of Echocardiography and European 
Association of Cardiovascular Imaging 2015.5 
The measurement of Cardiac Index (CI) was 
assessed by multiplying the Time Velocity 
Integral (TVI) and area of aorta, which was then 
multiplied by pulses per minute, and divided 
by body surface area. TAPSE was measured on 
four-chamber views. M-mode line was placed 
on the wall of tricuspid valve of the right cardiac 
chamber and the longitudinal systolic excursion 
distance was measured according to Guidelines 
for Echocardiographic Assessment of Right 
Heart in Adults issued by the American Society 
of Echocardiography in 2010.5 Troponin I and 
NT Pro BNP levels were examined using RAMP 
200 (R) and serum lactate level was measured 
using CobasAccutrend Plus (R). Venous oxygen 
saturation was assessed by blood gas analysis.
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Ethics
All patients or families of patients included in 
the study were given oral and written explanations 
about the research activity and subsequently 
they gave their informed consent. The protocol 
of our study has been approved by the Medical 
Research Ethics Committee, Faculty of Medicine 
Universitas Indonesia, Cipto Mangunkusumo 
Hospital with a reference number of 752/H2.F1/ 
ETIK/2013 issued on December 9th, 2013.
Statistical Analysis
Data analysis was performed using SPSS 
program version 20.0. The obtained data were 
then analyzed for data normality. Hypothesis test 
was carried out on two variable groups using t-test 
for numerical data or Mann Whitney test for non-
parametric data. Chi-square test was used for data 
on nominal group and whenever the requirements 
for its appropriate use had been met. Multivariate 
analysis was performed using Cox Regression 
model.
RESULTS
There were 111 study subjects consisting 
of 56 women and 55 men with mean age of 48 
(SD 18) years. Patients were observed for 10 
days. The number of patients who died were 64 
(56.64%) subjects. (Table 1)
Association Between Ventricular Function 
and Septic Shock Mortality
Low or abnormal left ventricle ejection 
fraction had increased the risk of mortality in 
patients with septic shock. (RR 1.6; 95%CI: 1.1 
– 2.1; p=0.034).
There were no differences between those 
with abnormal and normal value of diastolic 
function, cardiac indexes, TAPSE in association 
with septic shock mortality. (Table 2)
Patients who met the criteria for septic shock
Assessment of E/e' ratio, LVEF, Cardiac
Index, TAPSE, Troponin I, NT Pro BNP,
creatinine levels, and venous blood
oxygen saturation on day 1
Survived in the
Early phase of sepsis
Died in the
Early Phase of Sepsis
Assessment of E/e' ratio, LVEF, Cardiac
Index, TAPSE, Troponin I, NT Pro BNP,
creatinine levels, and venous blood oxygen
saturation on day 5
Died in the
Late Phase of Sepsis
Survived in the
Late Phase of Sepsis
Figure 1. Flow chart of the study protocol
Table 1. Subject characteristics of patients with septic 
shock
Characteristics (n=111) Total (%)
Gender
 - Male 55 (49)
 - Female 56 (51)
Age, year, mean (SD) 48 (SD 18)
Infection marker / microorganism found 111 (100)
Temp > 38.3 0C or < 36 0C 61 (55)
Pulse > 90/min 83 (75)
Respiratory rate >20/min 81 (73)
Altered Mental Status 85 (77)
Leucocytes count of >12.000 or < 4000 104 (94)
Blood sugar level of > 120 mg/dL in non-
DM patient 37 (433)
Mild Organ Dysfunction 14 (13)
Death 64 56.64)
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Association Between Cardiovascular 
Biomarkers, Venous Oxygen Saturation, 
Creatinine Levels on Day 1 and Septic Shock 
Mortality
The relative risk of mortality in patients with 
abnormal troponin I level was 1.6 and abnormal 
creatinine level was 1.5 (RR: 1.6; CI95%: 1.2 – 
2.1; p = 0.004 and RR: 1.5; CI95%: 1.1 – 2.1; p 
= 0.024). The relative risk of mortality in patients 
between those with abnormal and normal NT Pro 
BNP level and venous oxygen saturation was not 
different. (Table 3)
Patients with abnormal troponin I and 
abnormal creatinine level had a 5.7 times greater 
mortality risk compared to patients with normal 
troponin I and creatinine levels. (RR: 5.7; 
CI95%: 1.7 ̶ 18.5; p = 0.004). Patients with sepsis 
who have abnormal NT Pro BNP and abnormal 
creatinine levels had not been statistically proven 
to have greater risk of mortality.
Association Between Ventricular Function, 
Biomarker Cardiovascular and Time of 
Measurement with Death
The E/e’ ratio reflecting diastolic function, 
left ventricle ejection fraction and cardiac 
indexes were not different when they were 
measured on day 1 and day 5 (p = 0.531; p 
= 0.620 and p = 0.933). The TAPSE, which 
demonstrated the function of right heart, was 
found greater when it was measured on day 5 
compared to day 1 (p = 0.04). 
There were no differences found regarding 
cardiovascular biomarkers, troponin I and NT 
Table 2. Association of ventricularfunction on day 1 with septic shock mortality.
Ventricular Function
n (%)
RR (95% CI) P value
Death Life
Diastolic function (E/e') (n=95)
 - Abnormal (n=19) 10 (52.6) 9 (47.4) 0.98 (0.6  ̶  1.6) 0.918
 - Normal (n=76) 41 (53.9) 35 (46.1)
Left Ventricular Ejection Fraction (LVEF) (n=102)
 - Abnormal (n=15) 12 (80.0) 3 (20.0) 1.6 (1.1  ̶  2.1) 0.034
 - Normal (n=87) 44 (50.6) 43 (49.4)
Cardiac Index (n=97)
 - Abnormal (n=17) 7 (41.2) 10 (58.8) 0.7 (0.4  ̶  1.4) 0.349
 - Normal (n=80) 44 (55.0) 36 (45.3)
TAPSE (n=102)
 - Abnormal (n=15) 9 (60.0) 6 (40.0) 1.1 (0.7  ̶  1.8) 0.667
Table 3. Association between cardiovascular biomarkers, venous oxygen saturation, creatinine level on day 1 and septic 
shock mortality
Variables
n (%)
RR (95% CI) P value
Death Life
Troponin I level (n=111)
 - Abnormal (n = 38) 29 (76.3) 9 (23.7) 1.6 (1.2  ̶  2.1) 0.004
 - Normal (n = 73) 35 (47.9) 38 (52.1)
NT Pro BNP (n=111)
 - Abnormal (n = 104) 60 (57.7) 44 (42.3) 1.0 (0.5  ̶  2.0) 1.000
 - Normal (n = 7) 4 (57.1) 3 (42.9)
Venous O2 Saturation (n = 111)
 - Abnormal (n=40) 24 (60.0) 16 (40.0) 1.1 (0.8  ̶  1.5) 0.708
 - Normal (n=71) 40 (56.3) 31 (43.7)
Creatinine level (n=109)
 - Abnormal (n=53) 36 (67.9) 17 (32.1) 1.5 (1.1  ̶  2.1) 0.024
 - Normal (n=56) 26 (46.4) 30 (53.6)
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Pro BNP levels between those which were 
measured on day 1 and day 5. (P = 0.600 and 
p = 0.058). There were also no different results 
regarding echocardiography and cardiovascular 
biomarkers of patients who died prior to day 5 
compared to those who died after day 5.
We used the backward method for multivariate 
analysis. Variables with p value of less than 0.25 
were involved in the analysis including LVEF, 
troponin I  and creatinine levels and combination 
of abnormal troponin and creatinine levels. 
The multivariate analysis revealed that some 
variables had influence over patients’ mortality 
and they could be used as predictors of mortality 
in patients with septic shock, which were left 
ventricle ejection fraction and troponin I level. 
(HR: 1.99; CI95% 1.009  ̶  3.956; p = 0.047 and 
HR 1.83; CI95% 1.049  ̶  3.125; p = 0.043).
DISCUSSION
The E/e’ ratio of diastolic function reflects 
cardiac compliance. Any mean value of E/e’ 
of >14 indicates the occurrence of diastolic 
dysfunction. The value of E/e’ ratio can serve 
as a predictor for pulmonary capillary wedge 
pressure. Our study has demonstrated that 
the E/e’ ratio of diastolic dysfunction did not 
increase mortality risk; while a previous study 
conducted by Landesberg showed that patients 
whose diastolic function with E/e’ of < 8 may 
have increased risk of death by 6.0 times greater 
compare to normal patients.8 Sturgess et al12 who 
studied 20 hospitalized patients in an intensive 
care unit (ICU) showed that patients who died 
from septic shock had high E/e’ ratio of diastolic 
function. The different results found between 
our study and previous studies may be due 
to differences in time measurement. The Left 
Ventricle Ejection Fraction (LVEF) represents 
the amount of blood transferred compared to the 
initial blood volume during diastole. There is an 
increased risk of mortality in patients with sepsis 
who have low LVEF. A previous study conducted 
by Landesberg et al8 revealed that patients 
who suffer from severe sepsis and septic shock 
accompanied with systolic dysfunction (LVEF ≤ 
50%) had 2.9 greater mortality risks compared 
to normal patients. Patients with normal right 
heart function, which are represented by TAPSE 
measurement, have the same risk of mortality 
with patients who had abnormal right heart 
functions. Right heart function depends on 
pulmonary artery pressure and left ventricular 
end diastolic pressure. A previous study, which 
measured differences between area of right 
cardiac chamber during systole and diastole, 
showed that right heart function do not affect 
sepsis mortality.8 The study result is similar to 
our result. 
The cardiac Index is assessed by multiplying 
Time Velocity Integral and area of Aorta, which 
is then multiplied by heart rate per minute, and 
divided by body surface area. Patients with sepsis 
usually have increased heart rate to maintain 
perfusion requirements to the tissues. It is 
suspected that troponin I is released by myocytes 
due to impaired permeability and necrosis of 
myocytes as a consequence of microcircular 
thrombosis.13-15
Myocardial dysfunction occurs in patients 
with septic shock.16 NT Pro BNP level increases 
due to myocardial stretching.17,18 Troponin I and 
NT Pro BNP increase in patients with impaired 
renal function due to biomarker release by the 
kidneys. The right cardiac chamber function, 
which was assessed with TAPSE, was greater 
on the fifth day compared to the first day. Such 
results showed that patients who survived had 
improved right heart chamber function.
Results on troponin I, NT Pro BNP, and 
cardioivascular biomarkers level suggest that 
there was no difference found between those 
results measured on the first day and the fifth day. 
It indicates that the cellular mechanism involved 
on the first and fifth day has no difference. 
Patients with abnormal venous oxygen saturation 
had similar risks of mortality to patients with 
normal venous oxygen saturation. Such results 
indicate that venous oxygen saturation obtained 
from femoral vein or the femoral venous 
oxygen saturation could not represent regional 
oxygenation.
The limitation of this study are patients who 
had been hospitalized probably had already had 
septic shock condition before hospitalization; 
therefore, the target population in our study may 
have more severe condition. Comorbidities had 
not been considered in our study; while they may 
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have some effects on the mortality prediction 
model of septic shock patients.
CONCLUSION
Echocardiography variables (LVEF and 
troponin I biomarker), which were measured 
on day 1, have been demonstrated to be useful 
as predictors of mortality in patients with septic 
shock; however, other variables including the 
E/e’ ratio, cardiac index, TAPSE, NT ProBNP 
and creatinine levels as well as venous saturation 
are not useful as predictors.
Further studies are necessary to validate 
our study, particularly studies that involve 
comorbidities; moreover, further studies with 
additional variable of urine output will be useful 
to improve the accuracy of the mortality model 
prediction of septic shock patients. A 24-hour 
measurement of LVEF and troponin I level can 
serve as predictors of mortality risk in patients 
with septic shock.
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